Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Ioane Motsqales Sakhelo… | Healthcare Services | 3.0% | 30th pct | 268 |
| Mtskheta Medical Center | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 1 of 2 peers filed FY2024. Switch to FY2023 (2 of 2).
| Ratio — FY 2024 | Ioane Motsqales Sakhelo… | Mtskheta Medical Center |
|---|---|---|
| Margins | ||
| Gross Margin | 82.8% | — |
| EBITDA Margin | 3.0% | — |
| EBITDAR | 279 | — |
| EBITDAR Margin | 3.0% | — |
| EBIT Margin | -0.5% | — |
| Net Profit Margin | 3.3% | — |
| Operating Expense % of Sales | 79.7% | — |
| Returns | ||
| Return on Assets (ROA) | 3.2% | — |
| Return on Equity (ROE) | 7.7% | — |
| ROIC [EBIT / Invested Capital] | -0.6% | — |
| Leverage & debt balances | ||
| Debt-to-Assets | 42.4% | — |
| Debt-to-Equity | 1.03x | — |
| Debt-to-EBITDA | 14.45x | — |
| Equity-to-Assets | 41.3% | — |
| Net Debt | 4,005 | — |
| Cash & Equivalents | 32 | — |
| Total Debt | 4,037 | — |
| Liquidity & working capital | ||
| Current Ratio | 1.86x | — |
| Quick Ratio | 1.86x | — |
| Cash Ratio | 0.01x | — |
| Total Current Assets | 5,896 | — |
| Total Current Liabilities | 3,168 | — |
| Inventory | N/A | — |
| Trade Receivables | 1,069 | — |
| Trade Payables | 1,453 | — |
| Net Working Capital | 2,728 | — |
| Net Working Capital % of Revenue | 29.7% | — |
| Trade Working Capital | -385 | — |
| Trade Working Capital % of Revenue | -4.2% | — |
| Change in Trade Working Capital | N/A | — |
| Turnover & efficiency | ||
| Inventory Turnover | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | — |
| Receivables Turnover | 8.60x | — |
| Days Sales Outstanding (DSO) | 42.4 | — |
| Payables Turnover | 1.09x | — |
| Days Payable Outstanding (DPO) | 334.5 | — |
| Cash Conversion Cycle | -292.1 days | — |
| Asset Turnover | 0.97x | — |
| Cash flow & dividends | ||
| Operating Cash Flow | -67 | — |
| Free Cash Flow (OCF − Capex proxy) | -274 | — |
| Cash Conversion (OCF / EBITDA) | -23.9% | — |
| Dividends Declared | N/A | — |
| Dividend Payout Ratio | N/A | — |